Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 February 2023 | Story Rulanzen Martin | Photo Anja Aucamp
Samson Diamond, Jeanne-Louise Moolman, Prof Anmari van der Westhuizen-Joubert, and Sharon de Kock with the QoP instruments created by luthier Brian Lisus to honour SA’s Nobel peace laureates.

Hope, the viola; Freedom, the first violin; Peace, the second violin; and Reconciliation, the cello, collectively known as the Quartet of Peace (QoP), have found their home at the UFS. The Odeion String Quartet (OSQ) has been made the custodians of this world-famous quartet created by Brian Lisus. The instruments were created by Lisus in 2010 to commemorate the four Nobel peace laureates of South Africa, namely Albert Luthuli, Nelson Mandela, FW de Klerk, and Desmond Tutu. In March 2022, Lisus presented a lecture in the Odeion Theatre to officially present these instruments to the UFS.

Many new performing opportunities 

“The trustees found that justice will be done by making the Odeion String Quartet the new custodians, since they are the only quartet-in-residence at a South African university,” says Prof Anmari van der Westhuizen-Joubert, cellist and Head of the OSQ.

As the custodians of the QoP, it brought many new performing opportunities, both nationally and internationally. “It can also be used in presentations of lectures on all subjects and not only of a political nature. In this way, string quartet music reaches more people than just those who go to concert halls,” Prof Van der Westhuizen-Joubert says. The OSQ consists of Prof Van der Westhuizen-Joubert (cellist), Samson Diamond (violinist and leader of the string quartet), Sharon de Kock (violinist), and Jeanne-Louise Moolman (violinist).

Unique part of UFS identity

The uniqueness of the QoP instruments will be an important element of the OSQ, the Odeion School of Music, the Faculty of the Humanities, as well as the entire UFS community. “One of the plans is to raise money to enable students to come and study with the Odeion String Quartet members at the UFS,” Prof Van der Westhuizen-Joubert says. Another historic moment with these instruments took place in October 2022, when the instruments took centre stage at a concert hosted by Prof Francis Petersen, UFS Rector and Vice-Chancellor, at Constitution Hill in Johannesburg. At this event, the QoP instruments were introduced to the public, important stakeholders, and to guests of the UFS. Other plans include trips to international festivals such as the Ojai Music Festival in the USA in 2023 and the String Quartet Biennale in Amsterdam in 2024.

*This article  first appeared in the Bult Magazine.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept